Tracking the Invisible: The Commercial Potential of Minimal...

added blog Health

2025-11-21 07:25:34 -

Tracking the Invisible: The Commercial Potential of Minimal Residual Disease Monitoring

One of the most clinically transformative applications propelling the liquid biopsy market is Minimal Residual Disease (MRD) monitoring. MRD refers to the microscopic number of cancer cells or tumor DNA fragments that remain in the body after initial curative-intent treatment, such as surgery or chemotherapy, and which are often undetectable by conventional imaging techniques. The detection of...

0 Comments 0 Shares 97 Views 0 Reviews